593 



Health and Human Services, each year since 1984, a comprehen- 

 sive listing of cigarette ingredients. HHS has never indicated to 

 Lorillard at any time, in response to those submissions, that it had 

 a problem with respect to any individual ingredient or groups of in- 

 gredients. 



Indeed, when HHS asked the manufacturers for the quantity of 

 each ingredient being used, the manufacturers promptly provided 

 that information to HHS on a confidential basis. To my knowledge, 

 HHS has no outstanding requests to this manufacturer or any oth- 

 ers for additional information. 



The manufacturers, including Lorillard, have assured HHS re- 

 peatedly that we would be happy to meet with HHS officials, and/ 

 or HHS scientific consultants to answer any questions about ingre- 

 dients which the HHS or its consultants might have. I reaffirm 

 that commitment now. 



Finally, Mr. Chairman, allow me to sum up and to state 

 Lorillard's position on the principal issues raised in the statement 

 released by you when you scheduled today's hearings. In doing so, 

 it is also my purpose to respond to Dr. Kessler's erroneous asser- 

 tions first made on February 25th, and then expanded upon at your 

 March 25th hearing. 



Lorillard does not take any steps to assure a minimum level of 

 nicotine in our products. Lorillard does not add nicotine to cigarette 

 tobacco for the purpose of manipulating or spiking the amount of 

 nicotine receivea by the smoker. Lorillard makes no effort to keep 

 secret any information about the nicotine content of our products. 



And, as you know, since 1971, every cigarette advertisement has 

 carried a complete disclosure of the tar and nicotine content. Mr. 

 Chairman, I respectfully suggest to you that Lorillard has acted 

 and will continue to act in a completely responsible manner in this 

 as well all our business practices. 



Furthermore, I state unequivocally that our manufacturing proc- 

 esses neither violate the Federal Food, Drug, and Cosmetic Act, nor 

 do they justify placing the manufacture of cigarettes under the ju- 

 risdiction of the FDA. 



I thank you for your attention and for this opportunity to state 

 Lorillard's position. At the appropriate time. Dr. Spears and I will 

 take any questions you or your colleagues might have. Thank you. 



Mr. Waxman. Thank you, Mr. Tisch. 



Donald Johnston, president of American Tobacco Company. 



TESTIMONY OF DONALD S. JOHNSTON 



Mr. Donald Johnston. Thank you, Mr. Chairman. What I have 

 to say is repetitive from the statements already read, but I believe 

 these points do bear repetition as they focus on the facts concern- 

 ing the issues you raised in your letter inviting us to this hearing. 



Aside from tobacco itself, and federally authorized use of alcohol 

 denatured with minute amounts of nicotine, the American Tobacco 

 Company does not use nicotine in the manufacture of its cigarettes. 

 Contrary to the implications that have aired before this subcommit- 

 tee and elsewhere, the American Tobacco Company does not spike 

 its cigarettes with nicotine, or it does not use any of the patents 

 that have been placed before this subcommittee on any other like 

 processes or devices. 



